| Entry |
|
|---|
| Name |
Deutenzalutamide (USAN) |
|---|
| Formula |
C21H16F4N4O2S
|
|---|
| Exact mass |
467.1118
|
|---|
| Mol weight |
464.44
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01591 Androgen receptor antagonist
DG01624 Flutamide-type antiandrogen
|
|---|
| Efficacy |
Antineoplastic, Androgen receptor antagonist |
|---|
| Comment |
Treatment of prostate cancer
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01591 Androgen receptor antagonist
DG01624 Flutamide-type antiandrogen
D12303 Deutenzalutamide
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D12303 Deutenzalutamide (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 32
1 C8y C 19.3900 -28.9100
2 C8y C 19.3900 -30.3100
3 C8x C 18.2000 -31.0100
4 C8x C 16.9400 -30.3100
5 C8y C 16.9400 -28.9100
6 C8x C 18.2000 -28.2100
7 C1d C 20.5800 -28.2100
8 C3b C 20.5800 -31.0100
9 N3a N 21.7700 -31.7100
10 X F 21.7700 -27.5100
11 X F 21.2800 -29.4000
12 X F 19.8800 -27.0200
13 N1y N 15.7500 -28.2100
14 C5x C 14.5600 -28.9800
15 C1z C 13.4400 -28.0700
16 N1y N 13.9300 -26.8100
17 C2y C 15.3300 -26.8100
18 S0 S 16.2400 -25.7600
19 O5x O 14.4200 -30.3100
20 C1a C 12.1100 -28.4900
21 C1a C 13.1600 -29.4700
22 C8y C 13.1396 -25.6545
23 C8x C 13.8948 -24.4283
24 C8y C 13.2333 -23.1945
25 C8y C 11.8340 -23.1504
26 C8x C 11.0752 -24.3742
27 C8x C 11.7367 -25.6080
28 X F 13.9813 -21.9887
29 C5a C 11.1797 -21.9302
30 N1b N 9.8002 -21.8866
31 O5a O 11.9321 -20.7167
32 C1a C 9.1485 -20.6708
BOND 34
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 2 8 1
9 8 9 3
10 7 10 1
11 7 11 1
12 7 12 1
13 5 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 13 17 1
19 17 18 2
20 14 19 2
21 15 20 1
22 15 21 1
23 16 22 1
24 22 23 2
25 23 24 1
26 24 25 2
27 25 26 1
28 26 27 2
29 22 27 1
30 24 28 1
31 25 29 1
32 29 30 1
33 29 31 2
34 30 32 1
|
|---|
